Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Kidney Function Tests Market, by Product
1.4.2 North America Kidney Function Tests Market, by End Use
1.4.3 North America Kidney Function Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Kidney Function Tests Market - Global
Chapter 4. North America Kidney Function Tests Market by Product
4.1 North America Clearance Test Market by Country
4.2 North America Blood Tests Market by Country
4.3 North America Urine Tests Market by Country
4.4 North America Dilution & Concentration Tests Market by Country
4.5 North America Other Product Market by Country
Chapter 5. North America Kidney Function Tests Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Diagnostic Laboratories Market by Country
5.3 North America Research Laboratories and Institutes Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Kidney Function Tests Market by Country
6.1 US Kidney Function Tests Market
6.1.1 US Kidney Function Tests Market by Product
6.1.2 US Kidney Function Tests Market by End-use
6.2 Canada Kidney Function Tests Market
6.2.1 Canada Kidney Function Tests Market by Product
6.2.2 Canada Kidney Function Tests Market by End-use
6.3 Mexico Kidney Function Tests Market
6.3.1 Mexico Kidney Function Tests Market by Product
6.3.2 Mexico Kidney Function Tests Market by End-use
6.4 Rest of North America Kidney Function Tests Market
6.4.1 Rest of North America Kidney Function Tests Market by Product
6.4.2 Rest of North America Kidney Function Tests Market by End-use
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Danaher Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Siemens AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.5 Randox Laboratories Limited
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Quest Diagnostics, Incorporated
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Recent strategies and developments:
7.6.3.1 Partnerships, Collaborations, and Agreements:
7.6.3.2 Acquisition and Mergers:
7.7 Laboratory Corporation of America Holdings
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 ACON Laboratories, Inc.
7.9.1 Company Overview
7.10. Nova Biomedical Corporation
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Approvals:
Unique Offerings 